These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30504333)

  • 21. Iron overload in thalassemia: different organs at different rates.
    Taher AT; Saliba AN
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):265-271. PubMed ID: 29222265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the Benefit-Risk Ratio for Patients with Transfusion-Dependent Thalassemia Treated by Unrelated Cord Blood Transplantation Favorable?
    Jaing TH
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia.
    Marktel S; Scaramuzza S; Cicalese MP; Giglio F; Galimberti S; Lidonnici MR; Calbi V; Assanelli A; Bernardo ME; Rossi C; Calabria A; Milani R; Gattillo S; Benedicenti F; Spinozzi G; Aprile A; Bergami A; Casiraghi M; Consiglieri G; Masera N; D'Angelo E; Mirra N; Origa R; Tartaglione I; Perrotta S; Winter R; Coppola M; Viarengo G; Santoleri L; Graziadei G; Gabaldo M; Valsecchi MG; Montini E; Naldini L; Cappellini MD; Ciceri F; Aiuti A; Ferrari G
    Nat Med; 2019 Feb; 25(2):234-241. PubMed ID: 30664781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron Chelation Therapy as a Modality of Management.
    Aydinok Y
    Hematol Oncol Clin North Am; 2018 Apr; 32(2):261-275. PubMed ID: 29458731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapy for homozygous beta-thalassemia. Is it a reality?
    Boulad F; Rivière I; Sadelain M
    Hemoglobin; 2009; 33 Suppl 1():S188-96. PubMed ID: 20001625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry.
    Sullivan KM; Anasetti C; Horowitz M; Rowlings PA; Petersdorf EW; Martin PJ; Clift RA; Walters MC; Gooley T; Sierra J; Anderson JE; Bjerke J; Siadak M; Flowers ME; Nash RA; Sanders JE; Appelbaum FR; Storb R; Hansen JA
    Ann N Y Acad Sci; 1998 Jun; 850():312-24. PubMed ID: 9668553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving Ineffective Erythropoiesis in Thalassemia: A Hope on the Horizon.
    Madan U; Bhasin H; Dewan P; Madan J
    Cureus; 2021 Oct; 13(10):e18502. PubMed ID: 34754662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HSCT remains the only cure for patients with transfusion-dependent thalassemia until gene therapy strategies are proven to be safe.
    Oikonomopoulou C; Goussetis E
    Bone Marrow Transplant; 2021 Dec; 56(12):2882-2888. PubMed ID: 34531544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matched sibling donor hematopoietic stem cell transplantation for thalassemia.
    Issaragrisil S; Kunacheewa C
    Curr Opin Hematol; 2016 Nov; 23(6):508-514. PubMed ID: 27518930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system.
    Wattanapanitch M; Damkham N; Potirat P; Trakarnsanga K; Janan M; U-Pratya Y; Kheolamai P; Klincumhom N; Issaragrisil S
    Stem Cell Res Ther; 2018 Feb; 9(1):46. PubMed ID: 29482624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.
    Huang Y; Lei Y; Liu R; Liu J; Yang G; Xiang Z; Liang Y; Lai Y
    Int J Med Sci; 2019; 16(2):302-310. PubMed ID: 30745811
    [No Abstract]   [Full Text] [Related]  

  • 32. Incidence of ototoxicity in pediatric patients with transfusion-dependent thalassemia who are less well-chelated by mono- and combined therapy of iron chelating agents.
    Tanphaichitr A; Kusuwan T; Limviriyakul S; Atipas S; Pooliam J; Sangpraypan T; Tanphaichitr VS; Viprakasit V
    Hemoglobin; 2014; 38(5):345-50. PubMed ID: 25051423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cell transplantation for thalassemia.
    Issaragrisil S
    Int J Hematol; 2002 Aug; 76 Suppl 1():307-9. PubMed ID: 12430869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current management of thalassemia intermedia].
    Thuret I
    Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Therapeutic Advances in β-Thalassemia.
    Makis A; Voskaridou E; Papassotiriou I; Hatzimichael E
    Biology (Basel); 2021 Jun; 10(6):. PubMed ID: 34207028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic cellular gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic stem cell transplantation for thalassemia.
    Gaziev J; Lucarelli G
    Curr Stem Cell Res Ther; 2011 Jun; 6(2):162-9. PubMed ID: 21190532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in the allogeneic transplantation for thalassemia.
    Lucarelli G; Gaziev J
    Blood Rev; 2008 Mar; 22(2):53-63. PubMed ID: 18039551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G
    Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost Effectiveness of Hematopoietic Stem Cell Transplantation Compared with Transfusion Chelation for Treatment of Thalassemia Major.
    John MJ; Jyani G; Jindal A; Mashon RS; Mathew A; Kakkar S; Bahuguna P; Prinja S
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):2119-2126. PubMed ID: 29673692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.